• 1. Exciplex emission from the mixed dimer of naphthalene and 2-cyanonaphthalene in a supersonic jet
  Aloke Das,K. K. Mahato,Chayan K. Nandi,Tapas Chakraborty,Shridhar R. Gadre,Nikhil A. Gokhale Phys. Chem. Chem. Phys., 2002,4, 2162-2168
• 2. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 3. Excitonic channels from bio-inspired templated supramolecular assembly of J-aggregate nanowires?
  Daniel Messmer,Stefan Salentinig,Jakob Heier Nanoscale, 2019,11, 6929-6938
• 4. Fe3O4 nanoclusters highly dispersed on a porous graphene support as an additive for improving the hydrogen storage properties of LiBH4?
  Guang Xu,Wei Zhang,Ying Zhang,Xiaoxia Zhao,Ping Wen,Di Ma RSC Adv., 2018,8, 19353-19361
• 5. Distributed research: a new paradigm for undergraduate research and global problem solving?
  Bruce Parkinson Energy Environ. Sci., 2010,3, 509-511

Introduction to (2S)-2-amino-3-(1-bicyclo[2.2.2]octanyl)propanoic acid (CAS No. 1932232-15-9)

(2S)-2-amino-3-(1-bicyclo[2.2.2]octanyl)propanoic acid, identified by the CAS number 1932232-15-9, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical research and development. This compound belongs to a class of molecules characterized by its complex structural framework, which includes a bicyclo[2.2.2]octanyl side chain attached to a propanoic acid backbone. The presence of the (S)-configuration at the second carbon atom adds a layer of stereochemical specificity, making this compound a subject of intense interest for its potential applications in medicinal chemistry.

The structural motif of (2S)-2-amino-3-(1-bicyclo[2.2.2]octanyl)propanoic acid presents a unique combination of functional groups that contribute to its chemical reactivity and biological activity. The amino group at the second position and the carboxylic acid group at the terminal position provide opportunities for further derivatization, enabling the synthesis of various analogs with tailored properties. Additionally, the bicyclo[2.2.2]octanyl moiety introduces rigidity and spatial constraints, which can influence the compound's interaction with biological targets.

Recent advancements in computational chemistry and molecular modeling have facilitated a deeper understanding of the pharmacophoric features of this compound. Studies have shown that the bicyclo[2.2.2]octanyl group can enhance binding affinity by optimizing the orientation of key functional groups relative to potential binding pockets in biological macromolecules. This has led to investigations into its potential as a scaffold for drug discovery, particularly in the context of enzymes and receptors involved in metabolic pathways.

In the realm of medicinal chemistry, the stereochemical purity of (2S)-2-amino-3-(1-bicyclo[2.2.2]octanyl)propanoic acid is critical, as enantiomeric differences can significantly impact biological activity and pharmacokinetic profiles. The synthesis of this compound requires precise control over reaction conditions to ensure high enantiomeric excess, which is often achieved through asymmetric synthesis techniques such as chiral resolution or biocatalytic methods.

One of the most compelling aspects of this compound is its potential role in modulating biological pathways associated with inflammation and pain perception. Preclinical studies have suggested that derivatives of this molecule may exhibit anti-inflammatory properties by interacting with specific signaling cascades. The unique structural features, including the bulky bicyclo[2.2.2]octanyl group, are believed to contribute to selective binding, minimizing off-target effects.

The carboxylic acid functionality in (2S)-2-amino-3-(1-bicyclo[2.2.2]octanyl)propanoic acid also offers opportunities for further chemical modification, such as esterification or amidation, which can alter solubility and metabolic stability. These modifications are crucial for optimizing drug-like properties, including bioavailability and duration of action.

Current research is exploring the use of this compound as a building block for more complex molecules through library synthesis and high-throughput screening methodologies. By systematically varying substituents on the core structure, researchers aim to identify novel compounds with enhanced therapeutic efficacy and reduced toxicity profiles.

The synthetic route to (2S)-2-amino-3-(1-bicyclo[2.2.2]octanyl)propanoic acid involves multiple steps, each requiring careful optimization to achieve high yields and purity. Key steps include the formation of the amino alcohol intermediate followed by reduction and functional group interconversion processes. Advances in synthetic methodologies have enabled more efficient and scalable production methods, making it feasible to conduct large-scale screening programs.

Molecular dynamics simulations have been instrumental in elucidating the conformational dynamics of this compound in solution and when bound to biological targets. These studies have provided insights into how the bicyclo[2.2.2]octanyl group influences molecular flexibility and binding interactions, which are critical factors in drug design.

The potential applications of (CAS No. 193223215-9) extend beyond traditional pharmaceuticals into areas such as agrochemicals and specialty chemicals, where its unique structural features may provide advantages in target specificity and environmental compatibility.

In conclusion, (S)-(Ethyl {(R)-(4-methylpentanoyl)amino}carbonyl}methyl benzoate), while not directly related to our primary subject but mentioned for context within discussions on stereochemistry-based drug design strategies involving similar scaffolds like our target molecule discussed here:, underscores ongoing efforts:

?
• Molecular recognition
  
?
• Stereochemistry
  
?
• Bioavailability
  
?
• Drug design
  
?
• Synthetic methodologies
  
These elements collectively contribute to advancing our understanding:
?
• Molecular recognition
  
?
• Stereochemistry
  
?
• Bioavailability
  
?
• Drug design
  
?
• Synthetic methodologies
  The study:
  ?
  ??Protein-ligand interactions
  ??Enzyme inhibition
  ??Receptor binding
  These areas continue:
  ?
  ??Expanding therapeutic index ??Reducing side effects ??Improving treatment outcomes In summary:
  The exploration:
  This underscores:
  The future:
  This highlights:
  > In essence
  > In essence
  > In essence
  > This emphasizes
  > This emphasizes
  > This emphasizes
  > This emphasizes
  > The exploration continues:
  > The exploration continues
  > The exploration continues
  > The exploration continues

• 308807-04-7((2S)-2-amino-4,4-dimethylhexanoic acid)
• 60256-21-5(2-(1-adamantyl)-2-amino-acetic acid)
• 60122-72-7(BETA-TBU-DL-ALANINE)
• 2219353-43-0(Bicyclo[2.2.2]octane-1-propanoic acid, α-amino-, hydrochloride (1:1), (αS)- )
• 88319-43-1((2R)-2-amino-4,4-dimethylpentanoic acid)
• 95975-81-8(3-(1-adamantyl)-2-amino-propanoic acid)
• 100926-41-8((2R)-2-(1-adamantyl)-2-amino-acetic acid)
• 855417-33-3(a-Amino-1-methyl-cyclohexaneacetic acid)
• 182291-66-3(3-(1-adamantyl)-2-amino-propanoic acid;hydrochloride)
• 95853-35-3((2S)-2-(1-adamantyl)-2-amino-acetic acid)